Search results
Results from the WOW.Com Content Network
The COVID-19 vaccination campaign in Italy is a mass immunization campaign that was put in place by the Italian government in order to respond to the ongoing COVID-19 pandemic. It started on 27 December 2020, together with most countries in the European Union .
In December 2018, Moderna became a public company via the largest initial public offering of a biotechnology company in history, raising $621 million by selling 27 million shares at $23 per share. [25] [26] The first mRNA vaccine developed by Moderna was for influenza in 2015, and its first antibody encoded by mRNA was in 2019. [6]
As Moderna (NASDAQ: MRNA) looks to shore up its business in the wake of its declining coronavirus vaccine sales, it's natural for investors to wonder about where the biotech will go in the near ...
The first Italian region to start with vaccinations was Lazio, in the Spallanzani Hospital in Rome. On 6 January 2021, the European Medicines Agency (EMA) gave the green light to the Moderna vaccine. [208] On 1 May 2021, Italy reached 20 million vaccinated with a single dose and 6 million with double dose. [209] [210] [211]
Moderna stock gained 14%, shooting up to $48.56 per share Tuesday afternoon. Vaccine-makers Novavax and CureVac similarly rose, soaring 15% and 10%, respectively, while Pfizer gained 2% and GSK ...
Moderna's (NASDAQ: MRNA) sales are slowing down, and Moderna stock is going down -- a lot.. The coronavirus vaccine maker's shares plunged 21.2% through 10:20 a.m. ET Monday after it updated ...
The Moderna news followed preliminary results from the Pfizer-BioNTech vaccine candidate, BNT162b2, with Moderna demonstrating similar efficacy, but requiring storage at the temperature of a standard medical refrigerator of 2–8 °C (36–46 °F) for up to thirty days or −20 °C (−4 °F) for up to four months, whereas the Pfizer-BioNTech ...
(Reuters) -The European Union is in talks with Moderna over a new supply deal for the company's COVID-19 vaccines amid concerns over a rise in infections in the region, the Financial Times ...